| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 124, 649-654, Copyright © 1989 by Endocrine Society
ARTICLES |
DD Bikle and E Gee
Department of Medicine, Veterans Administration Medical Center, San Francisco, California 94121.
Greater than 99% of the total circulating 1,25-dihydroxyvitamin D [1,25- (OH)2D] is bound to proteins such as the vitamin D-binding protein (DBP) and albumin; in the normal human only 0.4% of the circulating 1,25-(OH)2D is free. Although it is often assumed that only the free concentration of 1,25-(OH)2D is available to cells, this has not been demonstrated. In particular, it is not clear whether the DBPs facilitate 1,25-(OH)2D entry into target cells or serve only to transport these metabolites within the circulation. To address this question, we evaluated one of the best characterized target tissue responses to 1,25-(OH)2D, namely its ability to inhibit its own production and induce that of 24,25-(OH)2D, using one of the most sensitive cells, the human foreskin keratinocyte. We incubated keratinocytes in the presence of 1,25-(OH)2D (from 10(-11)-10(-8) M) in medium containing albumin (from 0.1-10%) or serum (from 0.1-10%) for 4 h [to inhibit the 25-hydroxyvitamin D (250HD) 1 alpha-hydroxylase] or 16 h (to induce the 250HD 24-hydroxylase) before evaluating [3H]250HD metabolism by these cells during a 1-h incubation in serum- and albumin- free medium. The free fraction of 1,25-(OH)2D was determined in each medium by centrifugal ultrafiltration and varied from 36% to 0.57% in direct proportion to the albumin or serum in the medium. Increasing the serum or albumin concentration in the medium increased the concentration of total 1,25-(OH)2D needed to inhibit its own production or stimulate that of 24,25-(OH)2D. In contrast, the concentration of free 1,25-(OH)2D needed to half-maximally inhibit its own production or induce 24,25-(OH)2D production remained constant at approximately 10(- 11) M. We conclude that the free, not the total, 1,25-(OH)2D concentration regulates 250HD metabolism by keratinocytes, that DBPs do not facilitate 1,25-(OH)2D entry into the cell, and that these cells sense only free 1,25-(OH)2D.
This article has been cited by other articles:
![]() |
G. Jones Pharmacokinetics of vitamin D toxicity Am. J. Clinical Nutrition, August 1, 2008; 88(2): 582S - 586S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. H. Al-oanzi, S. P. Tuck, N. Raj, J. S. Harrop, G. D. Summers, D. B. Cook, R. M. Francis, and H. K. Datta Assessment of Vitamin D Status in Male Osteoporosis Clin. Chem., February 1, 2006; 52(2): 248 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Dusso, A. J. Brown, and E. Slatopolsky Vitamin D Am J Physiol Renal Physiol, July 1, 2005; 289(1): F8 - F28. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Inaba, H. Morii, T. Katsumata, H. Goto, E. Ishimura, T. Kawagishi, M. Kamao, T. Okano, and Y. Nishizawa Hyperparathyroidism Is Augmented by Ovariectomy in Nagase Analbuminemic Rats J. Nutr., June 1, 2000; 130(6): 1543 - 1547. [Abstract] [Full Text] |
||||
![]() |
A. J. Brown, A. Dusso, and E. Slatopolsky Vitamin D Am J Physiol Renal Physiol, August 1, 1999; 277(2): F157 - F175. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brown Regulation of vitamin D action Nephrol. Dial. Transplant., January 1, 1999; 14(1): 11 - 16. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |